A Solution for Improving Recruitment into Prodromal Alzheimer’s Disease Trials: CANTAB Recruit

Posted on 12 October 2016 in Clinical Trials

Screening patients into prodromal Alzheimer’s trials can be costly and time-consuming Kenton Zavitz, PhD, Director of Clinical Affairs & Rosemary Abbott, PhD, Principal Statistical Analyst look at a solution for improving recruitment into trials. 

Read on

The Challenge of Detecting Prodromal Alzheimer’s Disease for Clinical Trials

Posted on 5 October 2016 in Clinical Trials / Research

In this post, Director of Clinical Affairs, Dr Kenton Zavitz and Principal Statistical Analyst, Dr Rosemary Abbott look at the challenge of recruiting the correct patients into Alzheimer's disease trials.

Read on

What is test-retest reliability and why is it important?

Posted on 15 September 2016 in Research

Operational Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests.

Read on

How new technologies are expanding the reach of cognitive assessment

Posted on 1 September 2016 in

Dr Jenny Barnett, Chief Scientific Officer for Cambridge Cognition reviews how the rise of touchscreen technology has enabled the expansion of cognitive assessment. 

Read on

Evaluating familiarity deficits related to conversion of MCI to Alzheimer’s disease

Posted on 5 May 2016 in Research

The early identification of individuals at risk of Alzheimer's Disease (AD) is of primary importance for the development of new effective interventions to stop the progression of the disease before the onset of severe neurodegeneration and clinical manifestations. 

Read on

Brain Awareness Week 2016

Posted on 15 March 2016 in Research

Brain Awareness Week aims to raise awareness of the progress and benefits of brain research, which CANTAB has contributed to for over 30 years.

Read on